Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer
David J. Pinato(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Javier Marco‐Hernández(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), M. Carmen Carmona-García(München Klinik), Joanne Evans, Eudald Felip(University of Ioannina), Christopher C.T. Sng(University College Hospital), Daniele Generali(University of Trieste), Salvatore Grisanti(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Rachel Sharkey(Chelsea and Westminster Hospital), Diego Ottaviani(Royal London Hospital), N. Saoudi Gonzalez, Valeria Tovazzi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Andrea Patriarca(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Nadia Harbeck(Breast Center), Andrea Marrari(IRCCS Humanitas Research Hospital), Alberto Zambelli, Rachel Wuerstlein(LMU Klinikum), Sarah Benafif(Institute of Cancer Research), Alexia Bertuzzi(Humanitas University), Ramón Salazar(Institut Català d'Oncologia), Vittoria Fotia(Ospedale Papa Giovanni XXIII), Yien Ning Sophia Wong(CRUK Lung Cancer Centre of Excellence), Ricard Mesı́a(Institut d'Investigació Biomédica de Bellvitge), Thomas Newsom-Davis(Chelsea and Westminster Hospital), David García-Illescas(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Rossella Bertulli(Fondazione IRCCS Istituto Nazionale dei Tumori), Anna Carbó(Institut Català d'Oncologia), Salvatore Provenzano(Fondazione IRCCS Istituto Nazionale dei Tumori), Carlo Tondini(Ospedale Papa Giovanni XXIII), Palma Dileo(University College Hospital), Joan Brunet(Institut Català d'Ornitologia), Mark Bower(Chelsea and Westminster Hospital), Francesca D’Avanzo(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Isabel García-Fructuoso(Breast Cancer Research Foundation), Neha Chopra(Sutherland Hospital), Marta Betti(Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo), Federica Biello(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Oriol Mirallas(Hebron University), Daniela Ferrante(University of Washington), Bruno Vincenzi(Campus Bio Medico University Hospital), Alessia Dalla Pria(Hammersmith Hospital), Alvin Lee(Duke Medical Center), Antonio Maconi(United States Social Security Administration), Riccardo Bruna(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Roxana Reyes(Hospital Clínic de Barcelona), Elia Seguí, Michela Libertini(Fondazione Poliambulanza Istituto Ospedaliero), Gianpiero Rizzo(Policlinico San Matteo Fondazione), Claudia Andrea Cruz(Ospedale Papa Giovanni XXIII), Myria Galazi(Bank of Cyprus Oncology Center)
Cited by 183
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k